Krause, p., bruggemann, n., volzmann, s., horn, a., kupsch, a., schneider, g.H., lohmann, k., kuhn, a.Long-term effect on dystonia after pallidal deep brain stimulation (dbs) in three members of a family with a thap1 mutation.Journal of neurology.2015.Doi 1 0.1007/s00415-015-7908-z summary: deep brain stimulation (dbs) of the globus pallidus internus (gpi) is an established treatment in patients with severe dystonia.However, factors predicting outcome are largely unknown and motor improvement in dyt6 patients after dbs has been reported to be poorer as compared to, e.G., dyt1 patients.Here, we report the course of clinical improvement for up to 11 years of pallidal dbs in three male patients belonging to the same family with early-onset generalized or segmental dystonia due to a heterozygous thap1 gene mutation (dyt6).All patients showed an initial effective response to pallidal dbs with a mean of 56.9 ± 11.7 % improvement in the burke¿fahn¿marsden dystonia motor and 45.5 ± 22.4 % in the disability score at 1-year follow-up.The long-term outcome of pallidal dbs was favorable in two patients (39, 67 % motor improvement, respectively).Our findings demonstrate that motor improvement is variable and may depend on disease severity, disease duration, and clinical presentation.Overall, our observation supports pallidal dbs as an important treatment option in patients with dyt6 dystonia.Reported event: it was reported that the patient, who had pallidal deep brain stimulation (dbs) for severe generalized dystonia, had a clinically meaningful response initially, with 70.5% improvement in motor scores and 88.9% improvement in disability scores at the one year follow-up.However, the whole dbs system had to be explanted due to local electrode infection nine years after implantation.Dystonic symptoms, pain, and degree of disability worsened rapidly without dbs, so that bilateral pallidal dbs electrodes were re-implanted soon after successful antibiotic treatment.The source literature included the following device specifics: lead model 3387 and implantable neurostimulators itrel ii or kinetra model 7428 further information has been requested; a supplemental report will be submitted if additional information is received.
|